Advertisement
Advertisement

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
Intravital imaging of inflammation

DOI: http://dx.doi.org/10.1160/TH10-11-0698
Issue: 2011: 105/5(May) pp. 743-932
Pages: 864-872

Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis

M. Joner (1), R. A. Byrne (1), J.-M. Lapointe (2), P. W. Radke (3), G. Bayer (4), K. Steigerwald (1), E. Wittchow (4)

(1) Deutsches Herzzentrum München, Munich, Germany; (2) AccelLAB Inc, Boisbriand, Quebec, Canada; (3) Universitätsklinik Schleswig- Holstein, Campus Lübeck, Lübeck, Germany; (4) Biotronik SE & Co.KG, Berlin-Neukölln, Germany

Keywords

Restenosis, drug-eluting balloon, Porcine model

Summary

The advent of drug-eluting balloon (DEB) therapy has represented an important development in interventional cardiology. Nevertheless, preclinical data with this technology remain scant, and comparative studies have not previously been published. Bare metal stents were implanted in the coronary arteries of 15 pigs followed by balloon angioplasty. Animals were allocated to treatment with a 60-second inflation of one of four different balloon catheters: a conventional untreated plain angioplasty balloon (PBA, Biotronik AG), the Pantera Lux DEB (3.0 μg/mm2 paclitaxel; BTHC excipient, Biotronik AG), the Elutax DEB (2.0 μg/mm2 paclitaxel; no excipient; Aachen Resonance), or the SeQuent Please DEB (3.0 μg/mm2 paclitaxel; iopromide excipient: B. Braun). Twenty-eight days following balloon deployment, animals underwent repeat angiography for quantitative coronary angiography analysis and euthanasia for histopathologic assessment. By histology, the mean neointimal thickness was 0.44 ± 0.19 mm with PBA, 0.35 ± 0.13 mm with Pantera Lux , 0.61 ± 0.20 mm with Elutax , and 0.47 ± 0.21 mm with SeQuent Please DEB (p=0.02). In comparison with PBA, deployment of the Pantera Lux or the SeQuent Please DEB resulted in delayed healing characterised by significant increases in fibrin, neointimal cell vacuity and delayed re-endothelialisation. In conclusion, investigation of comparative DEB performance in a porcine model of advanced coronary restenosis reveals significant heterogeneity of neointimal suppression between the devices tested with numerically lowest values seen in the Pantera Lux group. On the other hand, evidence of delayed healing was observed in the most effective DEB groups.

You may also be interested in...

1.

Online Supplementary Material

T. Koppara (1), M. Joner (1), G. Bayer (2), K. Steigerwald (1), T. Diener (2), E. Wittchow (2)

Thromb Haemost 2012 107 6: 1161-1171

http://dx.doi.org/10.1160/TH12-01-0043

2.
Bodo Cremers1; Ulrich Speck2; Nicola Kaufels2; Dirk Mahnkopf3; Michael Kühler4; Michael Böhm1; Bruno Scheller1

Thromb Haemost 2009 101 1: 201-206

http://dx.doi.org/10.1160/TH08-06-0387

3.
R. Tölg, G. Richardt

Die Medizinische Welt 2008 59 5: 153-157